Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Satoshi, Ogino"'
Autor:
Syuji Yonekura, Yoshitaka Okamoto, Daiju Sakurai, Toshioki Sakurai, Tomohisa Iinuma, Heizaburou Yamamoto, Toyoyuki Hanazawa, Shigetoshi Horiguchi, Yuichi Kurono, Kohei Honda, Yuichi Majima, Keisuke Masuyama, Noriaki Takeda, Shigeharu Fujieda, Mitsuhiro Okano, Satoshi Ogino, Kimihiro Okubo
Publikováno v:
Allergology International, Vol 66, Iss 3, Pp 425-431 (2017)
Background: Complementary and alternative medicine (CAM) is extensively used in patients with allergic diseases worldwide. The purpose of this study was to investigate the actual situation of CAM practice in the treatment of allergic rhinitis. Method
Externí odkaz:
https://doaj.org/article/4de038743d7f4a509259f1a3c5149436
Autor:
Yuhya Wakasa, Noriaki Takeda, Kayoko Kawashima, Yuji Tohda, Toshio Tanaka, Masatoshi Kawata, Hidenori Takagi, Nobusuke Mino, Masaki Tanaka, Satoshi Ogino, YumShoji Hashimotoi, Makoto Takano
Publikováno v:
SC40202003240013
NARO成果DBa
C40201912240001_7517
NARO成果DBa
C40201912240001_7517
Background In allergic models, administration of rice that expresses a hybrid peptide consisting of 7 major T cell epitopes of Cry j 1 and Cry j 2 (7Crp), suppressed allergic symptoms, IgE elevation and specific T cell response to Japanese cedar poll
Autor:
Kimihiro Okubo, Yuichi Kurono, Shigeharu Fujieda, Satoshi Ogino, Eiichi Uchio, Hiroshi Odajima, Hiroshi Takenaka
Publikováno v:
Allergology International, Vol 63, Iss 3, Pp 357-375 (2014)
Like asthma and atopic dermatitis, allergic rhinitis is an allergic disease, but of the three, it is the only type I allergic disease. Allergic rhinitis includes pollinosis, which is intractable and reduces quality of life (QOL) when it becomes sever
Externí odkaz:
https://doaj.org/article/b271cef836e04ec182cb3229fe4a4a40
Autor:
Tomohiro Inaba, Takuto Goto, Tomo Aoyagi, Tomoyuki Hori, Keita Aoki, Yuya Sato, Noriaki Ono, Tsutomu Furihata, Hiroshi Habe, Satoshi Ogino, Atsushi Ogata
Publikováno v:
Chemical Engineering Journal. 450:138366
Autor:
Kimihiro Okubo, Yuichi Kurono, Shigeharu Fujieda, Satoshi Ogino, Eiichi Uchio, Hiroshi Odajima, Hiroshi Takenaka, Kohtaro Baba
Publikováno v:
Allergology International, Vol 60, Iss 2, Pp 171-189 (2011)
Like asthma and atopic dermatitis, allergic rhinitis is an allergic disease, but of the three, it is the only type I allergic disease. Allergic rhinitis includes pollinosis, which is intractable and reduces quality of life (QOL) when it becomes sever
Externí odkaz:
https://doaj.org/article/cc615b81314c415abe40d96a14b2df60
Autor:
Toru Hirano, Mari Kawai, Junsuke Arimitsu, Masako Ogawa, Yusuke Kuwahara, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Atsushi Ogata, Mihoko Koyanagi, Tomoko Kai, Ryosuke Shimizu, Masamitsu Moriwaki, Yukio Suzuki, Satoshi Ogino, Ichiro Kawase, Toshio Tanaka
Publikováno v:
Allergology International, Vol 58, Iss 3, Pp 373-382 (2009)
Background: Flavonoids are nutrients that exert anti-allergic effects. We investigated the preventative effect of enzymatically modified isoquercitrin (EMIQ), a flavonoid, to relieve the symptoms of Japanese cedar pollinosis. Methods: In a parallel-g
Externí odkaz:
https://doaj.org/article/08813bb8460c468da6a5e539447a4b34
Publikováno v:
Allergology International, Vol 57, Iss 3, Pp 257-263 (2008)
Background: H1 antihistamines are widely used as therapeutics for allergic diseases. Sedation is a well-known side effect of H1 antihistamines and sometimes it is life-threatening for patients. Thus it is important to evaluate the sedative properties
Externí odkaz:
https://doaj.org/article/00d7e66a2d5143b88a101c9ddc696b11
Autor:
Shoji Hashimoto, Masatoshi Kawata, Nobusuke Mino, Satoshi Ogino, Noriaki Takeda, Kayoko Kawashima, Hidenori Takagi, Yuhya Wakasa, Makoto Takano, Masaki Tanaka, Yuji Tohda, Toshio Tanaka
Publikováno v:
Asian Pacific Journal of Allergy & Immunology; Dec2022, Vol. 40 Issue 4, p386-392, 7p
Publikováno v:
Allergology International, Vol 55, Iss 4, Pp 379-386 (2006)
Background: Seasonal allergic rhinitis (SAR) induced by Japanese cedar pollen is a substantial problem in Japan. Omalizumab, a novel humanized monoclonal anti-immunoglobulin E (IgE) antibody, has already been proven to reduce symptoms associated with
Externí odkaz:
https://doaj.org/article/7338b693ff674ae6a18a13d0d91fc044
Autor:
Keiji Maeda, Toshio Tanaka, Yoshinobu Katada, Arata Horii, Kimihiro Nose, Hiroshi Ochi, Satoshi Ogino, Masaki Suemura, Tadamitsu Kishimoto, Tsuyoshi Igarashi
Publikováno v:
Allergology International, Vol 47, Iss 1, Pp 45-51 (1998)
To investigate the relationship between local responsiveness and allergic symptoms, bronchial and nasal responsiveness were measured in the following four groups of subjects: (i) bronchial asthma patients with serum house dust mite (HDM)-specific IgE
Externí odkaz:
https://doaj.org/article/910e8fa025884fc782aa6b8c86b0bde6